Neuroone Medical Technologies Corp
NeuroOne Medical Technologies Corporation, a medical technology company, provides solutions for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording in the United States. The company also provides solutions for spinal cord stimulation, brain stimulation, drug delivery and ablation solutions for patients suffering from epilepsy, trigeminal neuralgia, Parkinson'… Read more
Neuroone Medical Technologies Corp (NMTC) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.216x
Based on the latest financial reports, Neuroone Medical Technologies Corp (NMTC) has a cash flow conversion efficiency ratio of -0.216x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.53 Million) by net assets ($7.07 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Neuroone Medical Technologies Corp - Cash Flow Conversion Efficiency Trend (2010–2025)
This chart illustrates how Neuroone Medical Technologies Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Neuroone Medical Technologies Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Neuroone Medical Technologies Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
FNC ADD CULTURE. Co. Ltd
KQ:063440
|
0.017x |
|
Rockfields Property Indonesia Pt
JK:ROCK
|
0.027x |
|
MPM Corpóreos S.A
SA:ESPA3
|
0.056x |
|
NEWTON RESOURCES LTD
F:8NW
|
N/A |
|
PBA Holdings Bhd
KLSE:5041
|
0.093x |
|
Solnaberg Property AB
ST:SOLNA
|
0.034x |
|
NORDISK BERGTEKNIK SER.B
F:9LY
|
N/A |
|
SICHUAN ENG.INV.DEV.H YC1
F:84H
|
N/A |
Annual Cash Flow Conversion Efficiency for Neuroone Medical Technologies Corp (2010–2025)
The table below shows the annual cash flow conversion efficiency of Neuroone Medical Technologies Corp from 2010 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | $7.07 Million | $-2.84 Million | -0.401x | +97.01% |
| 2024-09-30 | $822.01K | $-11.01 Million | -13.396x | -549.64% |
| 2023-09-30 | $6.25 Million | $-12.89 Million | -2.062x | -163.38% |
| 2022-09-30 | $9.60 Million | $-7.52 Million | -0.783x | +40.35% |
| 2021-09-30 | $6.55 Million | $-8.60 Million | -1.313x | +20.82% |
| 2020-09-30 | $2.07 Million | $-3.43 Million | -1.658x | -138.02% |
| 2019-09-30 | $-1.24 Million | $-5.40 Million | 4.360x | +577.83% |
| 2018-09-30 | $-4.40 Million | $-2.83 Million | 0.643x | +711.35% |
| 2017-09-30 | $-266.22K | $-21.11K | 0.079x | -78.63% |
| 2016-09-30 | $-81.49K | $-30.23K | 0.371x | -49.84% |
| 2015-09-30 | $-35.39K | $-26.17K | 0.740x | -16.60% |
| 2014-09-30 | $-28.30K | $-25.09K | 0.887x | +11.30% |
| 2013-09-30 | $-17.24K | $-13.73K | 0.797x | 0.00% |
| 2012-09-30 | $-17.24K | $-13.73K | 0.797x | -90.48% |
| 2011-09-30 | $-3.28K | $-27.43K | 8.370x | +610.58% |
| 2010-09-30 | $-4.32K | $-5.09K | 1.178x | -- |